JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FURTHER FINANCIAL PRODUCTS

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FURTHER FINANCIAL PRODUCTS

PROFIT WARNING ANNOUNCEMENT ON THE CHANGE IN ANNUAL RESULTS FOR THE YEAR OF 2025

PROFIT WARNING ANNOUNCEMENT ON THE CHANGE IN ANNUAL RESULTS FOR THE YEAR OF 2025

SUPPLEMENTAL ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS:(1) 2026 STAIDSON RESEARCH AND DEVELOPMENT SERVICE  FRAMEWORK AGREEMENT; AND (2) 2026 BIOAI SERVICE FRAMEWORK AGREEMENT

SUPPLEMENTAL ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS:(1) 2026 STAIDSON RESEARCH AND DEVELOPMENT SERVICE FRAMEWORK AGREEMENT; AND (2) 2026 BIOAI SERVICE FRAMEWORK AGREEMENT

CONNECTED TRANSACTION BIORICHLAND LEASE (2025 RENEWAL) AGREEMENT

CONNECTED TRANSACTION BIORICHLAND LEASE (2025 RENEWAL) AGREEMENT

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top